Global Fluoroscopy Market Size, Share, Trends & Growth Analysis Report – Segmented By Surgery Type, End User and Region - Industry Forecast (2025 to 2033)
In 2024, the global surgical sutures market was valued at USD 2186.81 million and it is expected to reach USD 6.86 million by 2033 from USD 4.63 million in 2025, growing at a CAGR of 3.2 % during the forecast period.
Modern fluoroscopic systems incorporate digital imaging, flat-panel detectors, and radiation dose optimization features to enhance image quality while minimizing patient exposure. According to the World Health Organization (WHO), the global demand for advanced medical imaging technologies has surged due to rising prevalence of chronic diseases, growing geriatric populations, and increasing preference for less invasive treatment modalities. Additionally, technological advancements such as artificial intelligence integration, machine learning-based image enhancement, and portable fluoroscopic devices have expanded clinical applications beyond traditional hospital environments. Academic research institutions and healthcare providers are increasingly adopting these innovations to improve procedural accuracy, reduce complications, and streamline workflow efficiency.
One of the primary drivers of the fluoroscopy market is the escalating incidence of chronic diseases that necessitate image-guided diagnostic and therapeutic interventions. According to the World Health Organization (WHO), non-communicable diseases (NCDs) such as cardiovascular disorders, cancer, gastrointestinal conditions, and musculoskeletal ailments account for nearly 71% of global deaths annually. Many of these conditions require fluoroscopic guidance for accurate diagnosis and treatment planning. As noted by the Global Burden of Disease Study, cardiovascular diseases alone affect over 520 million people globally, with millions undergoing catheter-based interventions each year procedures that heavily rely on fluoroscopic imaging. Additionally, the International Diabetes Federation (IDF) reports that over 537 million adults suffer from diabetes, many of whom develop complications requiring vascular imaging and foot ulcer assessments guided by fluoroscopy. Moreover, the aging population is a key factor contributing to disease burden.
Another significant driver influencing the fluoroscopy market is the growing adoption of minimally invasive surgical (MIS) procedures, which rely heavily on real-time imaging for precision and safety. A key reason for this trend is the reduced recovery time, lower risk of complications, and shorter hospital stays associated with MIS compared to open surgery. As per the National Institutes of Health (NIH), patients undergoing fluoroscopically guided interventions experience up to 40% faster post-operative recovery than those receiving conventional surgical care. Furthermore, the rise in outpatient surgical centers equipped with advanced imaging capabilities has facilitated broader access to fluoroscopy-based interventions. As per the Ambulatory Surgery Center Association (ASCA), over 6,000 ambulatory surgery centers operate in the U.S., offering cost-effective and efficient alternatives to hospital-based procedures.
A major restraint affecting the fluoroscopy market is the growing concern over radiation exposure associated with prolonged use of fluoroscopic imaging during diagnostic and interventional procedures. According to the U.S. Food and Drug Administration (FDA), fluoroscopy can expose patients and medical personnel to radiation doses significantly higher than those of standard X-rays, increasing the long-term risk of radiation-induced cancers and tissue damage.
As reported by the National Cancer Institute (NCI), cumulative radiation exposure from repeated fluoroscopic procedures may contribute to elevated cancer risks, especially among patients undergoing multiple interventions and healthcare professionals working in interventional suites. This has prompted regulatory agencies such as the European Commission and the FDA to impose stricter guidelines on radiation safety protocols, equipment calibration, and operator training. Moreover, public awareness campaigns and legal actions against hospitals for excessive radiation incidents have heightened scrutiny over fluoroscopic device usage. As per the Joint Commission, several U.S. hospitals have been cited for failing to implement adequate radiation dose management strategies.
Another critical challenge facing the fluoroscopy market is the high acquisition and maintenance costs associated with advanced imaging systems. Additionally, ongoing expenses related to software upgrades, detector replacements, and service contracts further add to the financial burden for healthcare institutions. In resource-limited settings, budgetary constraints often result in outdated or poorly maintained fluoroscopic units, compromising image quality and patient safety. As per the World Health Organization (WHO), nearly 40% of medical imaging devices in sub-Saharan Africa are either obsolete or non-functional due to lack of funding for repairs and technical support. These economic barriers hinder widespread adoption of fluoroscopy, particularly in emerging markets where affordability and infrastructure limitations play a decisive role in procurement decisions.
An emerging opportunity shaping the fluoroscopy market is the integration of artificial intelligence (AI) and machine learning (ML) into imaging workflows to enhance diagnostic accuracy, reduce radiation exposure, and optimize procedural efficiency. According to the National Institutes of Health (NIH), AI-powered fluoroscopic systems are being developed to provide real-time image enhancement, automatic organ tracking, and intelligent dose modulation based on patient anatomy and movement patterns. Additionally, AI-enhanced fluoroscopic systems are expected to facilitate remote consultations and telemedicine applications, expanding access to expert-guided procedures in rural and underserved areas. As per the World Health Organization (WHO), digital health integration is becoming a priority in national healthcare strategies, particularly in developing economies aiming to strengthen diagnostic capabilities.
Another significant opportunity influencing the fluoroscopy market is the rising demand for portable and compact fluoroscopic devices, particularly in emergency medicine, ambulatory surgery centers, and field hospitals. According to the World Health Organization (WHO), the need for mobile diagnostic solutions has intensified following recent global health emergencies, which is prompting manufacturers to innovate in lightweight, battery-operated fluoroscopic systems. Furthermore, the shift toward decentralized healthcare models and the expansion of point-of-care diagnostics have created new use cases for compact fluoroscopic equipment.
An emerging opportunity shaping the fluoroscopy market is the integration of artificial intelligence (AI) and machine learning (ML) into imaging workflows to enhance diagnostic accuracy, reduce radiation exposure, and optimize procedural efficiency. According to the National Institutes of Health (NIH), AI-powered fluoroscopic systems are being developed to provide real-time image enhancement, automatic organ tracking, and intelligent dose modulation based on patient anatomy and movement patterns. Additionally, AI-enhanced fluoroscopic systems are expected to facilitate remote consultations and telemedicine applications, expanding access to expert-guided procedures in rural and underserved areas. As per the World Health Organization (WHO), digital health integration is becoming a priority in national healthcare strategies, particularly in developing economies aiming to strengthen diagnostic capabilities.
One of the most pressing challenges in the fluoroscopy market is the requirement for skilled technicians and specialized training to operate advanced imaging systems safely and effectively. According to the American Society of Radiologic Technologists (ASRT), proper operation of fluoroscopic equipment demands extensive knowledge of radiation physics, patient positioning, and image interpretation skills that are not uniformly available across all healthcare settings. As reported by the World Health Organization (WHO), there is a global shortage of trained radiographers and imaging specialists, particularly in low- and middle-income countries. In Sub-Saharan Africa, for instance, the ratio of radiologic technologists per million population is significantly lower than the global average, which is limiting access to fluoroscopic services in many regions. As per the European Society of Radiology (ESR), many hospitals face delays in deploying advanced fluoroscopic equipment due to the lack of adequately trained staff. Until workforce capacity keeps pace with technological advancements, the effective utilization of fluoroscopy remains a persistent challenge.
Another significant challenge affecting the fluoroscopy market is the imposition of stringent regulatory requirements aimed at ensuring patient safety, radiation protection, and device performance standards. According to the U.S. Food and Drug Administration (FDA), fluoroscopic devices must undergo rigorous pre-market approval processes, including clinical validation, electromagnetic compatibility testing, and radiation output verification before commercialization.
As per the International Electrotechnical Commission (IEC), regulatory frameworks such as IEC 60601-2-65 and IEC 61217 govern the safety and functionality of medical imaging equipment, adding layers of compliance complexity for manufacturers. The European Union’s Medical Device Regulation (MDR) further mandates enhanced clinical evidence and post-market surveillance, increasing the administrative and financial burden on companies seeking market entry. Moreover, evolving guidelines on radiation exposure limits and mandatory reporting of adverse events have raised operational costs for healthcare providers.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| CAGR | 4.30% |
| Segments Covered | By Surgery Type, End User, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Market Leaders Profiled | GE Healthcare., Orthoscan Inc., Hologic Inc., Shimadzu Corporation |
The Cardiovascular Interventions segment held 38.1% of the fluoroscopy market share in 2024. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, with an estimated 17.9 million deaths recorded annually. As reported by the American Heart Association (AHA), over 4 million interventional cardiology procedures were performed in the U.S. alone in 2022, all of which required fluoroscopic guidance for precision and safety. Additionally, advancements in hybrid operating rooms equipped with integrated imaging systems have expanded the use of fluoroscopy in complex cardiac surgeries.
The orthopedic surgeries segment is lucratively to grow with a CAGR 7.4% during the forecast period. According to the World Health Organization (WHO), musculoskeletal conditions affect more than 1.7 billion people globally, making them one of the most common causes of chronic pain and disability. Fluoroscopy plays a critical role in orthopedic surgery by enabling precise implant placement, intraoperative alignment assessments, and fracture reduction verification. Furthermore, the expansion of outpatient orthopedic centers and the development of mobile C-arm systems tailored for orthopedic applications are contributing to increased adoption.
The Hospitals segment was the largest and held prominent share of the fluoroscopy market share in 2024. According to the World Bank, there are over 43,000 hospitals across OECD countries alone, many of which are equipped with advanced imaging suites to support a wide range of fluoroscopically guided procedures. A key driver behind this segment’s dominance is the presence of comprehensive healthcare infrastructure and regulatory mandates requiring hospitals to maintain high standards of diagnostic accuracy and procedural efficiency. Additionally, hospitals serve as primary training centers for radiologists and interventional specialists by ensuring continued reliance on fluoroscopy for both routine diagnostics and complex surgeries. Moreover, government funding initiatives aimed at upgrading medical imaging capabilities in public hospitals have reinforced this segment’s position.
The Diagnostic Centers segment is swiftly emerging with a projected CAGR of 8.3% during the forecast period. According to the U.S. Centers for Medicare & Medicaid Services (CMS), outpatient diagnostic imaging utilization has grown by more than 20% in the past five years, driven by favorable reimbursement policies and patient preference for shorter wait times and lower costs. Another major factor driving this trend is the rise in preventive healthcare screening programs, especially in developed nations where early detection of conditions like osteoporosis and gastrointestinal disorders is emphasized.
North America was the top performer in the global fluoroscopy market by capturing 35.3% of share in 2024. A key growth driver is the increasing integration of artificial intelligence and machine learning into fluoroscopic workflows, enhancing image quality while reducing radiation exposure. Additionally, regulatory agencies such as the FDA continue to implement guidelines promoting safer and more efficient use of fluoroscopy in clinical settings. Furthermore, the presence of leading manufacturers such as GE Healthcare, Siemens Healthineers, and Philips Healthcare has fostered continuous innovation and competitive product development.
Europe fluoroscopy market ranked second with 21.4% of the share in 2024 due to its well-developed healthcare systems, robust research environment, and emphasis on regulatory compliance. Countries such as Germany, the United Kingdom, and France are among the leading contributors, benefiting from extensive use of fluoroscopy in both public and private healthcare settings. According to the European Society of Radiology (ESR), Europe performs over 40 million diagnostic imaging procedures annually, with fluoroscopy playing a crucial role in interventional radiology and surgical applications. Another major growth driver is the increasing prevalence of cardiovascular and musculoskeletal disorders. As per the World Health Organization (WHO), cardiovascular diseases account for nearly 45% of all deaths in the European region, reinforcing the need for image-guided interventions. Moreover, the region is witnessing growing investment in digital health solutions, including AI-enhanced fluoroscopic imaging platforms.
Asia-Pacific fluoroscopy market is esteemed to have significant growth opportunities in the next coming years. Growing healthcare expenditure, increasing chronic disease burden, and government-led modernization of medical infrastructure are prompting the growth of the market. China, Japan, and India are among the leading markets, supported by rising investments in hospital upgrades and diagnostic center networks. According to the World Bank, healthcare spending in Asia-Pacific has increased by more than 6% annually over the past decade, with governments focusing on improving access to advanced imaging technologies. In India, the Ministry of Health and Family Welfare has launched multiple initiatives to strengthen radiology services under the Ayushman Bharat scheme, facilitating broader access to fluoroscopy-based diagnostics. Additionally, Japan’s aging population and high prevalence of osteoporosis and cardiovascular diseases have led to increased use of fluoroscopy in geriatric care.
Latin America fluoroscopy market growth is driven with Brazil and Mexico serving as primary contributors. The region’s growth is primarily driven by increasing access to diagnostic imaging, rising prevalence of chronic diseases, and government initiatives aimed at improving healthcare infrastructure.
Middle East and Africa fluoroscopy market is driven with notable variations in adoption levels across different sub-regions. Saudi Arabia, the United Arab Emirates, and South Africa are among the leading contributors, which is benefiting from government-backed healthcare modernization programs and strategic investments in medical imaging infrastructure.
Companies leading the global fluoroscopy market profiled in the report are GE Healthcare., Orthoscan Inc., Hologic Inc., Shimadzu Corporation, Siemens Medical Solutions, Philips N.V., Hitachi Ltd., Toshiba Medical Systems Corporation, Ziehm Imaging GmbH, and Amico X-ray innovations.
The competition in the fluoroscopy market is characterized by a mix of established multinational corporations and emerging regional players striving to capture market share through technological differentiation and strategic expansion. Global leaders such as GE Healthcare, Siemens Healthineers, and Philips Healthcare dominate due to their extensive product portfolios, robust R&D capabilities, and strong brand recognition in both developed and emerging economies.
These companies benefit from long-standing relationships with hospitals, academic institutions, and government health programs by ensuring consistent procurement and service contracts. Their ability to integrate artificial intelligence, machine learning, and cloud-based imaging analytics into fluoroscopic platforms gives them a competitive edge over smaller firms.
However, mid-tier and independent manufacturers are gaining traction by offering cost-effective alternatives tailored to budget-conscious healthcare providers, particularly in Asia-Pacific and Latin America. These firms focus on modular design, ease of maintenance, and affordability without compromising core performance metrics.
Additionally, regulatory compliance and radiation safety standards play a crucial role in shaping market dynamics. Companies that successfully navigate evolving guidelines while maintaining innovation pipelines are better positioned to sustain its dominance in this highly specialized and technically demanding sector.
GE Healthcare is a leading global provider of fluoroscopic imaging systems, known for its innovative and high-performance diagnostic and interventional solutions. The company offers a broad portfolio of fluoroscopy equipment designed to support cardiovascular, gastrointestinal, orthopedic, and urological applications. GE Healthcare plays a critical role in advancing imaging technology through continuous R&D investments and digital integration strategies.
Siemens Healthineers is a key player in the fluoroscopy market, offering cutting-edge imaging platforms that combine superior image quality with radiation dose optimization. The company’s commitment to integrating artificial intelligence and machine learning into fluoroscopic workflows has positioned it as a leader in next-generation medical imaging technologies.
Philips Healthcare contributes significantly to the global fluoroscopy market by delivering advanced, patient-centric imaging solutions tailored for complex interventional procedures. Philips focuses on smart connectivity, AI-assisted diagnostics, and compact system designs that cater to both hospital and outpatient settings, which is reinforcing its strong presence across diverse healthcare environments.
One of the primary strategies employed by key players in the fluoroscopy market is continuous innovation and product development by focusing on AI-integrated imaging systems, low-dose radiation technologies, and portable fluoroscopic devices that enhance clinical outcomes while improving operational efficiency.
Another major approach involves expanding geographic reach through strategic partnerships, acquisitions, and localized distribution networks, which is enabling companies to strengthen their foothold in emerging markets where demand for cost-effective and accessible imaging solutions is growing rapidly.
Companies are increasingly prioritizing digital transformation and integration with telemedicine platforms , allowing remote diagnostics, real-time collaboration between specialists, and enhanced workflow automation to meet evolving healthcare delivery models and improve access to fluoroscopic imaging worldwide.
In January 2023, GE Healthcare launched an AI-enhanced fluoroscopic imaging platform featuring real-time dose modulation and automated organ tracking, which is aiming to improve procedural accuracy and reduce radiation exposure during interventional surgeries.
In August 2023, Siemens Healthineers expanded its manufacturing facility in Germany to increase production capacity for next-generation hybrid operating room fluoroscopy systems by supporting rising demand from cardiac and vascular surgery centers across Europe and North America.
In March 2024, Philips Healthcare introduced a new line of compact mobile C-arm fluoroscopy units designed for use in ambulatory surgical centers and field hospitals, which is enhancing accessibility and flexibility in point-of-care diagnostics.
In November 2024, Canon Electron Tubes & Devices partnered with a U.S.-based software firm to develop AI-driven fluoroscopic image enhancement tools, aimed at improving visualization and reducing manual interpretation errors during minimally invasive procedures.
In May 2025, Shimadzu Corporation launched a radiation-reduction module for existing fluoroscopy systems, allowing retrofitting of older units with advanced dose management features, which is addressing growing concerns around patient and staff safety in clinical settings.
This research report on the global fluoroscopy market segmented and sub-segmented into the following categories.
By Surgery Type
By End User
By Region
Frequently Asked Questions
GE Healthcare., Orthoscan Inc., Hologic Inc., Shimadzu Corporation, Siemens Medical Solutions, Philips N.V., Hitachi Ltd., Toshiba Medical Systems Corporation, Ziehm Imaging GmbH and Amico X-ray innovations are some of the notable companies in the fluoroscopy market.
The worldwide fluoroscopy market size was valued at USD 2186.81 million in 2024.
Based on type, the cardiovascular intervention segment had the leading share of the global market in 2025.
The Asia-Pacific is predicted to grow the fastest in the worldwide market during the forecast period.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region